<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[fda and ivax corp. Resources | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/fda+and+ivax+corp..html]]></link>
	<description><![CDATA[White papers, case studies, business articles, and blog posts relating to fda and ivax corp.]]></description>
	<s:counts start="0" returned="10" found="17" />
	<language>en-us</language>
	<item>
		<title><![CDATA[IVAX Receives Final Approval on 600 and 800 mg Gabapentin Tablets]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2005_May_2/ai_n13664170]]></link>
		<description><![CDATA[MIAMI -- IVAX Corporation (AMEX:IVX) (LSE:IVX.L) (WSE:IVX) announced today that it received final approval on April 29, 2005 from the U.S. Food and Drug Administration FDA for its Abbreviated New Drug Application ANDA for gabapentin 600 and 800 mg tablets. Upon FDA approval, IVAX' wholly owned subsidiary, IVAX Pharmaceuticals, Inc.,...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 02 May 2005 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/ivax+corp..html"><![CDATA[IVAX Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/tablet.html"><![CDATA[tablet]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IVX</category>
		<category domain="tickers">IVX</category>
	</item>
	<item>
		<title><![CDATA[IVAX Receives Final FDA Approval for Anagrelide HCl Capsules]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2005_April_18/ai_n13628780]]></link>
		<description><![CDATA[MIAMI -- IVAX Corporation (AMEX:IVX) (LSE:IVX.L) (WSE:IVX) has received final approval from the U.S. Food and Drug Administration FDA for its Abbreviated New Drug Application ANDA for anagrelide HCl capsules in 0.5 and 1 mg dosage strengths. This product will be sold through IVAX' wholly owned subsidiary, IVAX Pharmaceuticals, Inc....]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 18 Apr 2005 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/ivax+corp..html"><![CDATA[IVAX Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IVX</category>
		<category domain="tickers">IVX</category>
	</item>
	<item>
		<title><![CDATA[IVAX Receives New Drug Approval for Proprietary Asthma Product]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2004_Nov_1/ai_n6277573]]></link>
		<description><![CDATA[MIAMI -- IVAX Corporation (AMEX: IVX, LSE: IVX.L) received approval from the United States Food and Drug Administration FDA for its New Drug Application NDA for its patented HFA (CFC-free) formulation of albuterol in a metered dose inhaler MDI for the treatment of asthma. The product will be marketed by...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 01 Nov 2004 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/ivax+corp..html"><![CDATA[IVAX Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IVX</category>
		<category domain="tickers">IVX</category>
	</item>
	<item>
		<title><![CDATA[IVAX Receives FDA Approvable Letter for Albuterol HFA in Breath-Activated Inhaler]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2004_July_7/ai_n6096882]]></link>
		<description><![CDATA[MIAMI -- IVAX Corporation (AMEX:IVX)(LSE:IVX.L) announced today that it has received an approvable letter from the United States Food and Drug Administration FDA for its New Drug Application NDA for albuterol sulfate using non-ozone-depleting, CFC-free propellant in IVAX' patented breath-activated aerosol inhaler.]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 07 Jul 2004 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/ivax+corp..html"><![CDATA[IVAX Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IVX</category>
		<category domain="tickers">IVX</category>
	</item>
	<item>
		<title><![CDATA[U.S. District Court Extends TRO Against FDA Until November 21st]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2003_Nov_18/ai_n27681508]]></link>
		<description><![CDATA[Business Editors/Health/Medical Writers  MIAMI--BUSINESS WIRE--Nov. 18, 2003  IVAX Corporation (AMEX:IVX) (LSE:IVX.L) announced that the U.S. District Court in Washington D.C. has extended its temporary restraining order against the United States Food and Drug Administration ("FDA") in the Metformin ER case for three more days, ending at the close...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 18 Nov 2003 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/ivax+corp..html"><![CDATA[IVAX Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/u.s.+district+court.html"><![CDATA[U.S. District Court]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IVX</category>
		<category domain="tickers">IVX</category>
	</item>
	<item>
		<title><![CDATA[IVAX Corp. (Active Pharmaceutical Ingredient Watch).(was 1 of 4 firms to get FDA approval for generic version of AstraZeneca's Nolvadex, tamoxifen)(Brief Article)]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb4250/is_200303/ai_n13306932]]></link>
		<description><![CDATA[IVAX Corp. was one of four companies to receive FDA approval for  its generic version of AstraZeneca PLC'S 10mg and 20mg breast  ...    IVAX Corp. was one of four companies to receive FDA approval for  its generic version of AstraZeneca PLC'S 10mg and 20mg...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 03 Mar 2003 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/astrazeneca+plc..html"><![CDATA[AstraZeneca Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/ivax+corp..html"><![CDATA[IVAX Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IVX</category>
		<category domain="tickers">AZN,IVX</category>
	</item>
	<item>
		<title><![CDATA[IVAX Receives FDA Approvals for Two Brand Equivalent Products]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2002_July_1/ai_88114860]]></link>
		<description><![CDATA[Business Editors/Health & Medical Writers]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 01 Jul 2002 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/brand.html"><![CDATA[brand]]></category>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/ivax+corp..html"><![CDATA[IVAX Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IVX</category>
		<category domain="tickers">IVX</category>
	</item>
	<item>
		<title><![CDATA[IVAX' Gabapentin Approvable by FDA]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2002_May_7/ai_85494614]]></link>
		<description><![CDATA[Business Editors/Health & Medical Writers]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 07 May 2002 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/ivax+corp..html"><![CDATA[IVAX Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IVX</category>
		<category domain="tickers">IVX</category>
	</item>
	<item>
		<title><![CDATA[IVAX GETS FINAL APPROVAL FOR METFORMIN.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb6494/is_200203/ai_n25837260]]></link>
		<description><![CDATA[IVAX Corporation (AMEX:IVX) (LSE:IVX.L), Miami, has received final  approval for its Abbreviated New Drug Application ANDA for sales of  metformin hydrochloride tablets in 500 mg, 625 mg, 750 mg, 850 mg and  1000 mg strengths from the United States Food and Drug Administration  FDA. Metformin hydrochloride...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 01 Mar 2002 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/ivax+corp..html"><![CDATA[IVAX Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/oakwood+healthcare+inc..html"><![CDATA[Oakwood Healthcare Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IVX</category>
		<category domain="tickers">IVX</category>
	</item>
	<item>
		<title><![CDATA[Court slams FDA decision on Ivax patent]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_qa5351/is_200201/ai_n21308241]]></link>
		<description><![CDATA[WASHINGTON INSIDER  ]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 01 Jan 2002 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/ivax+corp..html"><![CDATA[IVAX Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IVX</category>
		<category domain="tickers">IVX</category>
	</item>
</channel>
</rss>
